RESPONSE BIOMEDICAL CORP. AWARDED CAPITAL EQUIPMENT SUPPLIER CONTRACT BY VIZIENT, INC.
Response Biomedical Corp. (RBM.T) has been awarded a three-year capital equipment supplier contract with Vizient Inc. for Response’s cardiovascular and infectious disease product lines.
Vizient, the largest member-owned health care company in the United States, serves a diverse membership and customer base including academic medical centres, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers. The new contract offers savings to those Vizient members who had access to the Novation contracts for Response’s innovative RAMP platform with tests for key cardiac care markers such as troponin I and NT-proBNP and tests for infectious diseases such as influenza A and B.
“Response is very pleased to be working with Vizient,” said Dr. Barbara Kinnaird, chief executive officer of Response. “Through this partnership, Response will gain direct access to a very large number of target customers in the United States. Vizient provides a gold-standard approach to cost performance and contract terms, resulting in a positive customer experience by simplifying the contract process and streamlining the supply chain between members and suppliers,” added Dr. Kinnaird.